Yep. Have to wait until mid-October for my six months to pass, but most definitely getting the booster.
Going this afternoon for a 4:30-5 appointment. I hit 6 months 9-26.
I suppose this will become an annual deal at minimum. Now that it has been unleashed on the world, we are never going to eradicate it much like we can't eradicate the flu since it morphs from year to year. At best we will be able to offer some degree of protection, anywhere from 100% to at least possibly minimizing the impact it has on our system.
If everybody had like minds, we would never learn.
Back in February my girlfriend, also a nurse, got the Pfizer, I got the Moderna. Her blood antibodies have since waned. She’s getting a booster in a couple of weeks. My weekly blood tests still show strong antibodies. I’m holding off for a bit. When they start to wane in my tests I’ll sign up for my next jab.
She’s been working heavily with COVID patients recently. Sadly the COVID units around town are full again. Thankfully the death rates are down but the virus is still spreading throughout the nursing home facilities like wildfire.
They're going to fill you up with tracking nanochips, so they can track what your doing.
you know cause like that's not possible with cell phones, social media, public webcams, credit cards, intrnet surfing, etc, already
Actually, my nanobots all busted. I guess they all got stuck to the magnetized injection site and just broke down from there, so it's all good. I just wish that I could walk by my refrigerator without sticking to it.
Blue ostriches on crack float on milkshakes between the sidewalk titans of gurglefitz. --YTown
Is it still for seniors and people who are immunocompromised?
Here's the full list of who can get it (which seems like anyone could actually get it if really they wanted to, just say you're a former smoker)
People 65 years and older and those in long-term care facilities Those aged 50–64 with underlying medical conditions People 18-49 with underlying medical conditions Those aged 18-64 who are at increased risk for COVID-19 exposure and transmission because of occupational or institutional setting
What constitutes an underlying medical condition:
Chronic kidney disease Chronic lung diseases, such as chronic obstructive pulmonary disease or asthma Dementia or other neurological conditions Diabetes Down syndrome Heart conditions, such as heart failure, coronary artery disease, or cardiomyopathies Hypertension Liver Disease Overweight, obesity Pregnancy, Sickle cell disease or thalassemia Smoking (current or former) Stroke Substance abuse disorders
All health care workers All teachers/staff/employees in K-12, preschool and childcare settings All first responders, including law enforcement and correctional personnel, public safety, fire services and emergency management officials
I too received the Moderna. I don't have the luxury of weekly or monthly testing for antibodies. So where I stand in that regard is a mystery to me. I qualify for a booster and considering the circumstances I plan to get a Moderna booster when one becomes available.
Intoducing for The Cleveland Browns, Quarterback Deshawn "The Predator" Watson. He will also be the one to choose your next head coach.
It’s not much of a “luxury” in that we put ourselves in harm’s way nearly daily. Therefore the COVID tests we receive are a part of the layers of protection we cast over ourselves.
…but I do get what you’re saying. I’ll admit on some level it’s nice to have access to the knowledge the tests provide. I’m grateful for that.
Merck says COVID-19 pill cuts risk of death, hospitalization By MATTHEW PERRONE
Pharmaceutical company Merck & Co. said Friday, Oct. 1, 2021, that its experimental COVID-19 pill reduced hospitalizations and deaths by half in people recently infected with the coronavirus and that it would soon ask health officials in the U.S. and around the world to authorize its use. (Merck & Co. via AP)
WASHINGTON (AP) — In a potential leap forward in the global fight against the pandemic, drugmaker Merck said Friday that its experimental pill for people sick with COVID-19 reduced hospitalizations and deaths by half.
If cleared by regulators, it would be the first pill shown to treat COVID-19, adding a whole new, easy-to-use weapon to an arsenal that already includes the vaccine.
The company said it will soon ask health officials in the U.S. and around the world to authorize the pill’s use. A decision from the U.S. Food and Drug Administration could come within weeks after that, and the drug, if it gets the OK, could be distributed quickly soon afterward.
All other COVID-19 treatments now authorized in the U.S. require an IV or injection. A pill taken at home, by contrast, would ease pressure on hospitals and could also help curb outbreaks in poorer and more remote corners of the world that don’t have access to the more expensive infusion therapies.
“This would allow us to treat many more people much more quickly and, we trust, much less expensively,” said Dr. William Schaffner, an infectious disease expert at Vanderbilt University who was not involved in the research.
Merck and its partner Ridgeback Biotherapeutics said early results showed patients who received the drug, molnupiravir, within five days of COVID-19 symptoms had about half the rate of hospitalization and death as those who received a dummy pill.
The study tracked 775 adults with mild-to-moderate COVID-19 who were considered high risk for severe disease because of health problems such as obesity, diabetes or heart disease. The results have not been reviewed by outside experts, the usual procedure for vetting new medical research.
Among patients taking molnupiravir, 7.3% were either hospitalized or died at the end of 30 days, compared with 14.1% of those getting the dummy pill. After that time period, there were no deaths among those who received the drug, compared with eight in the placebo group, according to Merck.
The results were so strong that an independent group of medical experts monitoring the trial recommended stopping it early.
Company executives said they plan to submit the data to the FDA in the coming days.
Even with the news of a potentially effective new treatment, experts stressed the importance of vaccines for controlling the pandemic, given that they help prevent transmission and also reduce the severity of illness in those who do get infected.
White House coronavirus coordinator Jeff Zients said that vaccination will remain the government’s main strategy for controlling the pandemic. “We want to prevent infections, not just wait to treat them when they happen,” he said.
Dr. Anthony Fauci, the government’s foremost authority on infectious diseases, called the results from Merck “very good news.”
Merck only studied its drug in people who were not vaccinated. But FDA regulators may consider authorizing it for broader use in vaccinated patients who get breakthrough COVID-19 symptoms.
Andrew Pekosz of Johns Hopkins University predicted vaccines and antiviral drugs would ultimately be used together to protect against the worst effects of COVID-19.
“These shouldn’t be seen as replacements for vaccination — the two should be seen as two strategies that can be used together to significantly reduce severe disease,” said Pekosz, a virology specialist.
Patients take four pills of molnupiravir twice a day for five days. Side effects were reported by both groups in the Merck trial, but they were slightly more common among those who received a dummy pill. The company did not specify the problems.
Earlier study results showed the drug did not benefit patients who were already hospitalized with severe disease. That’s not surprising, given that antiviral drugs are most effective when used before the virus ramps up in the body.
The U.S. has approved one antiviral drug, remdesivir, for COVID-19, and allowed emergency use of three antibody therapies that help the immune system fight the virus. But all the drugs are expensive and have to given by IV or injection at hospitals or clinics, and supplies have been stretched by the latest surge of the delta variant.
The antibody drugs have been shown to reduce hospitalization and death by roughly 70% when given to high-risk patients, roughly 20 percentage points more than Merck’s pill. But experts cautioned against comparing results from the two, given the preliminary nature of Merck’s data.
Health experts, including Fauci, have long called for a convenient pill that patients could take when COVID-19 symptoms first appear, much the way Tamiflu is given to help speed recovery from the flu.
Like other antivirals, Merck’s pill works by interfering with the virus’s ability to copy its genetic code and reproduce itself.
The U.S. government has committed to purchasing enough pills to treat 1.7 million people, assuming the FDA authorizes the drug. Merck said it can produce pills for 10 million patients by the end of the year and has contracts with governments worldwide. The company has not announced prices.
Several other companies, including Pfizer and Roche, are studying similar drugs and could report results in the coming weeks and months.
Merck had planned to enroll more than 1,500 patients in its late-stage trial before the independent board stopped it early. The results reported Friday included patients across Latin America, Europe and Africa. Executives estimated 10% of patients studied were from the U.S.
This story has been updated to correct that patients take eight pills per day, not two.
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.
I got the J&J shot, will I be able to the pfizer booster? I’ve looked and cant find anything saying yes or no
At this point in time, it is not felt that the J&J vaccinated need a booster at this point. There are several reasons why only Pfizer needs a booster right now.
One is that it was approved 1st so the other vaccines have not had as long to wane. Another is that Pfizer chose to use a lower dose of vaccine to minimize side effects. Moderna is a higher dose so the protection lasts longer, but they also have a higher incidence of myocarditis etc.
As for getting boosted with a different vaccine, they are referring to that as hybrid immunity and studies are underway. We should have some information in the next month or two. I think the information will show that hybrid immunity is preferred but we don't have enough data yet to make any solid conclusions, therefore the recommendation for now is to get boosted with the same vaccine.
Don't blame the clown for acting like a clown. Ask yourself why you keep going to the circus.
They're going to fill you up with tracking nanochips, so they can track what your doing.
you know cause like that's not possible with cell phones, social media, public webcams, credit cards, intrnet surfing, etc, already
You laugh but I have connections. For those of you that do choose to get vaccinated, I suggest you do what my insider contact recommends. After you get vaccinated, within 24 hours, you need to turn on your microwave and stand with the vaccination site near the microwave. It will mess of the tracking capabilities of the nanochips. Kind of like how the microwave messes with a pacemaker. A couple of things are important to remember:
1, must be done within 24 hours of getting vaccinated. Wait any longer and the nanachips will have dispersed so this will be ineffective.
2. the vaccination site must be within 1 foot (12 inches) of the microwave.
3, It has to be at least a 1200 watt microwave. 1000 watt microwave may do the job but not reliably so
4, This is my own personal helpful tip. Make sure you put something in the microwave. At least a cup of water. If you run an empty microwave that long it can damage it.
Don't blame the clown for acting like a clown. Ask yourself why you keep going to the circus.
Both my wife and I got our booster shots last Friday afternoon.
On Saturday morning we left for Florida. I had wanted to get down around the Tampa area on our way to Venice, but I started to have some negative reactions I didn't experience with the first two shots. Finally I had to pull off for the day in Gainesville.
I felt a bit different on Saturday morning when we left but by the time I called it a day I was pretty stiff in the neck and had a fever. We didn't take a thermometer, but it was fairly low level...maybe 100 tops, but I normally read out low 97, so 100 was feeling pretty warm to me.
I was fine the next morning after a good night of pretty deep sleep.
My wife was fine with the booster.
Last edited by Ballpeen; 10/05/2108:44 AM.
If everybody had like minds, we would never learn.
![[Linked Image]](http://www.dawgtalkers.net/uploads/small-gator-chomp.gif)
![[Linked Image]](http://www.dawgtalkers.net/uploads/PortlandDawg/banner.jpg)
